Answers are grounded in this paper and cite their sources.
MPNSTs are highly aggressive in NF1. Conventional chemotherapy does not seem to reduce mortality, and its role must be questioned. Recent advances in the molecular biology of MPNSTs may provide new prognostic factors and targeted therapies.
No takes yet. Share an insight, caveat, or question.
Zehou et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: